Published Date: 07 Mar 2023
The Delhi High Court, which rejected the city government's appeal, recently upheld a judge's order ordering the government to pay...
Read Full NewsDr Wilkoff wonders what the effects will be of 12 states proposing changes to restricted foods under SNAP.
The Trump administration is considering appointing Houman Hemmati, an ophthalmologist and a frequent Fox News guest, to lead the FDA's Center for Biologics Evaluation and...
Medical residents report limited structured training in AI and digital health despite increasing clinical relevance.
Reusable catheter strategies may be as safe as single-use devices for preventing UTIs, but questions remain about their practical use.
New research suggests the loss of the corneal reflex — a classic marker of brain death — could help clinicians make more specific assessments during the final days and hours of life.
Taking three doses of ibuprofen before the insertion of an intrauterine device reduces pain during the procedure compared with a placebo.
A study of nine AI chatbots found hallucination rates from 0% to 34%, with Grok 3 performing the worst and Perplexity Research being most reliable.
1.
Severe obesity associated with reduced prevalence of recommended cancer screenings
2.
Emicizumab in Infants With Hemophilia A: Safe and Effective Use.
3.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
4.
Alkem introduces cetuximab under the trade name Cetuxa in India.
5.
Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.
1.
Gut microbiota in curing cancer
2.
Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs
3.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
4.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
5.
Improving TIVAP Use: Review of Standardization and Optimization Practices
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation